Q2 2025 · 13F-HR
Avidity Partners Management LPholdings as filed
Filed 2025-08-14 · accession 0001791827-25-000007
$502.0M
Reported value
56
Positions
2025-06-30
Period end
The Brief · Avidity Partners Management LP · Q2 2025
AI · grounded in 13F
Avidity Partners Management LP established a new position in CGON valued at $38.9M. The fund also initiated new stakes in BSX for $34.5M and NTRA for $33.6M. Additional new positions include DNTH at $32.4M, EXK at $18.8M, and THC at $18.6M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 156944100 | CGON | CG ONCOLOGY INC | $39.0M | 7.77% | 1,499,942 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $34.6M | 6.89% | 321,800 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $33.7M | 6.71% | 199,300 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $32.5M | 6.47% | 1,742,902 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $18.9M | 3.76% | 355,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $18.7M | 3.72% | 106,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $18.4M | 3.66% | 210,500 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $17.7M | 3.53% | 89,700 | Common | SOLE |
| 433313103 | HNGE | HINGE HEALTH INC | $16.7M | 3.32% | 322,344 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGIVAL INC | $14.7M | 2.93% | 27,100 | Common | SOLE |
| 372303206 | GMAB | GENMAB A/S | $13.4M | 2.68% | 650,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $13.2M | 2.64% | 106,500 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $12.0M | 2.39% | 29,600 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $11.6M | 2.30% | 689,500 | Common | SOLE |
| 008064206 | JBIO | JADE BIOSCIENCES INC | $11.3M | 2.24% | 1,127,186 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $10.2M | 2.03% | 1,064,500 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $10.0M | 1.99% | 32,000 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $9.9M | 1.97% | 13,500 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $9.9M | 1.97% | 94,500 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $9.8M | 1.96% | 32,800 | Common | SOLE |
| 42226A107 | HQY | HEALTHEQUITY INC | $9.6M | 1.92% | 92,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $9.1M | 1.81% | 74,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $8.4M | 1.68% | 228,600 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $7.2M | 1.42% | 134,000 | Common | SOLE |
| 68170A108 | OMDA | OMADA HEALTH INC | $7.1M | 1.42% | 390,600 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $7.0M | 1.39% | 409,400 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $6.7M | 1.34% | 27,600 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $6.4M | 1.27% | 1,858,596 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $6.2M | 1.23% | 640,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $6.0M | 1.20% | 140,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $5.9M | 1.18% | 59,000 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $5.8M | 1.15% | 19,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $5.6M | 1.12% | 154,000 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $4.9M | 0.98% | 7,477,255 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $3.9M | 0.79% | 352,124 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $3.9M | 0.78% | 5,615,811 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $3.8M | 0.75% | 268,000 | Common | SOLE |
| 26622P107 | DOCS | DOXIMITY INC | $3.7M | 0.73% | 60,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $3.4M | 0.67% | 107,891 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $3.2M | 0.64% | 33,800 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $3.2M | 0.63% | 340,000 | CALL | SOLE |
| N90064101 | QURE | UNIQURE NV | $2.9M | 0.57% | 207,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $2.8M | 0.56% | 65,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $2.7M | 0.53% | 32,000 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $2.5M | 0.50% | 15,000 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $2.4M | 0.49% | 140,000 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $2.3M | 0.46% | 502,600 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $2.2M | 0.43% | 232,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $1.8M | 0.37% | 39,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $1.8M | 0.36% | 243,162 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $1.4M | 0.28% | 150,000 | Common | SOLE |
| 811292200 | SCYX | SCYNEXIS INC | $829,268 | 0.17% | 1,228,910 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $579,979 | 0.12% | 134,566 | Common | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $406,350 | 0.08% | 105,000 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $226,678 | 0.05% | 11,300 | Common | SOLE |
| 76152G100 | — | REVIVA PHARMACEUTICALS HOLDING | $52,592 | 0.01% | 138,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.